Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy - PubMed (original) (raw)

Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy

Mohamed M Elseweidy et al. Exp Biol Med (Maywood). 2013.

Abstract

Diabetic nephropathy (DN) is one of the major complications that develop as consequence of chronic and uncontrolled hyperglycaemia. Hyperglycaemia initiates various processes, one of which is protein glycation, leading to the formation of advanced glycation end products. Alteration of intracellular signalling, gene expression, release of proinflammatory molecules and free radicals are examples of such changes and they contribute to the initiation of diabetic complications. In the current manuscript, we studied the effect of pyridoxamine (PM) on protein glycation, oxidative stress, interleukin-1α (IL-1α), IL-6, C-reactive protein (CRP), gene expression of tumour necrosis factor-α (TNF-α) and transforming growth factor-β1 (TGF-β1) in relation to microalbuminuria and kidney functions in a model of alloxan-induced diabetic rats. We have observed that onset of microalbuminuria has preceded the gradual increase of blood sugar level in diabetic rats. In diabetic rats, gene expression of TNF-α and TGF-β1 recorded a gradual increase and marked increase was observed after one and two weeks of alloxan administration, in comparison with normal rats. PM induced significant decrease in kidney malondialdehyde content and the gene expression of TNF-α and TGF-β1, in addition to levels of serum glucose, fructosamine, urea, creatinine, IL-1α, IL-6, CRP and urine microalbumin. Histopathological examination of kidney tissues showed certain improvements as compared with diabetic control. In conclusion, our results may provide a supporting evidence for the therapeutic benefit of PM in DN.

Keywords: Nephropathy; malondialdehyde; microalbuminuria; pyridoxamine; transforming growth factor-β1; tumour necrosis factor-α.

PubMed Disclaimer

Cited by

The Protective Effects of Vitamin B Complex on Diclofenac Sodium-Induced Nephrotoxicity: The Role of NOX4/RhoA/ROCK.
Attia H, Badr A, Alshehri O, Alsulaiman W, Alshanwani A, Alshehri S, Arafa M, Hasan I, Ali R. Attia H, et al. Inflammation. 2024 Oct;47(5):1600-1615. doi: 10.1007/s10753-024-01996-6. Epub 2024 Feb 28. Inflammation. 2024. PMID: 38413451
Manipulating the Amount and Structure of the Organic Matrix Affects the Water Compartments of Human Cortical Bone.
Nyman JS, Uppuganti S, Unal M, Leverant CJ, Adabala S, Granke M, Voziyan P, Does MD. Nyman JS, et al. JBMR Plus. 2019 Jan 28;3(6):e10135. doi: 10.1002/jbm4.10135. eCollection 2019 Jun. JBMR Plus. 2019. PMID: 31346566 Free PMC article.
SIRT4 overexpression protects against diabetic nephropathy by inhibiting podocyte apoptosis.
Shi JX, Wang QJ, Li H, Huang Q. Shi JX, et al. Exp Ther Med. 2017 Jan;13(1):342-348. doi: 10.3892/etm.2016.3938. Epub 2016 Nov 30. Exp Ther Med. 2017. PMID: 28123512 Free PMC article. Retracted.
Pyridoxamine Treatment of HK-2 Human Proximal Tubular Epithelial Cells Reduces Oxidative Stress and the Inhibition of Autophagy Induced by High Glucose Levels.
Wang Y, Li Y, Yang Z, Wang Z, Chang J, Zhang T, Chi Y, Han N, Zhao K. Wang Y, et al. Med Sci Monit. 2019 Feb 25;25:1480-1488. doi: 10.12659/MSM.914799. Med Sci Monit. 2019. PMID: 30799433 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy - PubMed (original) (raw)